2020 annual financial data
Sutro Biopharma 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -158.71%.
Operating income was -71,057,000 USD and net income was -32,128,000 USD.
Operating cash flow was -67,802,000 USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,722,000 USD
- Operating income
- -71,057,000 USD
- Net income
- -32,128,000 USD
- Operating cash flow
- -67,802,000 USD